FDA Raises Thyroid Tablet Recall To Most Serious Level

FDA Raises Thyroid Tablet Recall To Most Serious Level Authored by Jack Phillips via The Epoch Times, The Food and Drug Administration this week elevated a prescription thyroid medication recall to its most serious classification because the medication is too potent. Medications are stored on shelves at a pharmacy in Los Angeles on May 12, 2025. Eric Thayer/Getty ImagesSeveral weeks ago, Vitruvias Therapeutics said in a notice published by the FDA that it was voluntarily recalling one lot of thyroid tablets because the medication is "superpotent" and can "cause hyperthyroidism," or an...